{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:46:50Z","timestamp":1790480810190,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.biopha.2021.111913","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T03:40:19Z","timestamp":1626147619000},"page":"111913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells"],"prefix":"10.1016","volume":"141","author":[{"given":"Guojuan","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2021.111913_bib1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1074-7613(03)00147-X","article-title":"B7S1, a novel B7 family member that negatively regulates T cell activation","volume":"18","author":"Prasad","year":"2003","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.biopha.2021.111913_bib2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(03)00152-3","article-title":"B7-H4, a molecule of the B7 family, negatively regulates T cell immunity","volume":"18","author":"Sica","year":"2003","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/j.biopha.2021.111913_bib3","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1073\/pnas.1434299100","article-title":"B7x: A widely expressed B7 family member that inhibits T cell activation","volume":"100","author":"Zang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2021.111913_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory pathways in the B7-CD28 ligand-receptor family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2021.111913_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40259-012-0001-6","article-title":"Targeting the B7 family of Co-stimulatory molecules","volume":"27","author":"Podojil","year":"2013","journal-title":"BioDrugs"},{"issue":"12","key":"10.1016\/j.biopha.2021.111913_bib6","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1158\/1078-0432.CCR-15-2440","article-title":"Molecular pathways: evaluating the potential for B7-H4 as an immunoregulatory target","volume":"23","author":"MacGregor","year":"2017","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biopha.2021.111913_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/695834","article-title":"The inhibitory role of B7-H4 in antitumor immunity: association with cancer progression and survival","volume":"2011","author":"He","year":"2011","journal-title":"Clin. Dev. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111913_bib8","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.171.9.4650","article-title":"Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family","volume":"171","author":"Choi","year":"2003","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"issue":"5","key":"10.1016\/j.biopha.2021.111913_bib9","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1158\/1078-0432.CCR-04-1658","article-title":"B7-H4 is highly expressed in ductal and lobular breast cancer","volume":"11","author":"Tringler","year":"2005","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111913_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygyno.2007.03.039","article-title":"B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration","volume":"106","author":"Miyatake","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111913_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yexcr.2005.01.018","article-title":"The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation","volume":"306","author":"Salceda","year":"2005","journal-title":"Exp. Cell Res."},{"issue":"12","key":"10.1016\/j.biopha.2021.111913_bib12","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.humimm.2014.10.002","article-title":"B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas","volume":"75","author":"Wang","year":"2014","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111913_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5732\/cjc.009.10158","article-title":"[Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance]","volume":"29","author":"Zhang","year":"2010","journal-title":"Chin. J. Cancer"},{"issue":"18","key":"10.1016\/j.biopha.2021.111913_bib14","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.1158\/0008-5472.CAN-07-1866","article-title":"Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma","volume":"67","author":"Kryczek","year":"2007","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.biopha.2021.111913_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1665460","article-title":"Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer","volume":"8","author":"MacGregor","year":"2019","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.biopha.2021.111913_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12935-018-0597-9","article-title":"B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer","volume":"18","author":"Wang","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2021.111913_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41523-018-0095-1","article-title":"Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer","volume":"4","author":"Altan","year":"2018","journal-title":"NPJ Breast Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2021.111913_bib18","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3390\/jcm8101566","article-title":"Correlation between B7-H4 and survival of non-small-cell lung cancer patients treated with nivolumab","volume":"8","author":"Genova","year":"2019","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.111913_bib19","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3892\/ol.2020.11701","article-title":"Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8","volume":"20","author":"Li","year":"2020","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2021.111913_bib20","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00262-010-0900-7","article-title":"Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer","volume":"59","author":"Jiang","year":"2010","journal-title":"Cancer Immunol.\u00a0Immunother."},{"issue":"4","key":"10.1016\/j.biopha.2021.111913_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1724600819881147","article-title":"The prognostic value of B7H1 and B7H4 expression in pancreatic cancer: a meta-analysis, The","volume":"34","author":"Qi","year":"2019","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.biopha.2021.111913_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2013.04.001","article-title":"B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10\/Treg-dependent mechanisms","volume":"44","author":"Podojil","year":"2013","journal-title":"J. Autoimmun."},{"issue":"17","key":"10.1016\/j.biopha.2021.111913_bib23","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1128\/MCB.00755-06","article-title":"Generation and characterization of B7-H4\/B7S1\/B7x-deficient mice","volume":"26","author":"Suh","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111913_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.immuni.2018.03.018","article-title":"Co-inhibitory molecule B7 superfamily member 1 expressed by tumor-infiltrating myeloid cells induces dysfunction of anti-tumor CD8(+) T cells","volume":"48","author":"Li","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2021.111913_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1744897","article-title":"Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma","volume":"9","author":"Podojil","year":"2020","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.biopha.2021.111913_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.12530","article-title":"Potential targeting of B7-H4 for the treatment of cancer","volume":"276","author":"Podojil","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2021.111913_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.104008","article-title":"B7-H4, a promising target for immunotherapy","volume":"347","author":"Wang","year":"2020","journal-title":"Cell Immunol."},{"key":"10.1016\/j.biopha.2021.111913_bib28","doi-asserted-by":"crossref","first-page":"v489","DOI":"10.1093\/annonc\/mdz253.024","article-title":"FPA150 (B7-H4 antibody) phase I update in advanced solid tumours: monotherapy and in combination with pembrolizumab","volume":"30","author":"Wainberg","year":"2019","journal-title":"Ann. Oncol."},{"issue":"498","key":"10.1016\/j.biopha.2021.111913_bib29","article-title":"Differences between pediatric and adult T cell responses to in vitro staphylococcal enterotoxin B stimulation","volume":"9","author":"Rudolph","year":"2018","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.biopha.2021.111913_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239023","article-title":"Exploring the potential use of a PBMC-based functional assay to identify predictive biomarkers for anti-PD-1 immunotherapy","volume":"21","author":"Bacot","year":"2020","journal-title":"Int J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221006958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221006958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:34:33Z","timestamp":1776461673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221006958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"alternative-id":["S0753332221006958"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111913","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111913"}}